These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark
One)
|
|
|
☒
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
|
|
For the quarterly period ended March 31, 2021
|
|
|
OR
|
|
☐
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
|
|
For the
transition period from to
|
|
Montana
|
|
81-0305822
|
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
|
Common
Stock, $0.01 par value
|
UAMY
|
NYSE
American
|
|
Large
Accelerated Filer ☐
|
Accelerated Filer
☐
|
|
Non-Accelerated
Filer
☐
|
Small
Reporting Company
☒
Emerging Growth
Company ☐
|
|
|
Page
|
|
PART I
– FINANCIAL INFORMATION
|
|
|
|
|
|
Item
1: Financial Statements (unaudited)
|
1-15
|
|
|
|
|
Item
2: Management’s Discussion and Analysis of Results of
Operations and Financial Condition
|
16-20
|
|
|
|
|
Item
3: Quantitative and Qualitative Disclosure about Market
Risk
|
20
|
|
|
|
|
Item
4: Controls and Procedures
|
20
|
|
|
|
|
PART
II – OTHER INFORMATION
|
|
|
|
|
|
Item
1: Legal Proceedings
|
21
|
|
|
|
|
Item
2
:
Unregistered Sales of
Equity Securities and Use of Proceeds
|
21
|
|
|
|
|
Item
3: Defaults upon Senior Securities
|
21
|
|
|
|
|
Item
4: Mine Safety Disclosures
|
21
|
|
|
|
|
Item
5: Other Information
|
21
|
|
|
|
|
Item
6: Exhibits and Reports on Form 8-K
|
21
|
|
|
|
|
SIGNATURE
|
22
|
|
|
|
|
CERTIFICATIONS
|
|
|
ASSETS
|
||
|
|
March
31,
2021
|
December
31,
2020
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
23,042,330
|
$
665,102
|
|
Certificates of
deposit
|
254,873
|
254,212
|
|
Accounts
receivable
|
537,567
|
238,634
|
|
Inventories
|
717,750
|
650,213
|
|
Other current
assets
|
52,200
|
-
|
|
Total current
assets
|
24,604,720
|
1,808,161
|
|
|
|
|
|
Properties, plants
and equipment, net
|
11,026,428
|
11,225,594
|
|
Restricted cash for
reclamation bonds
|
57,275
|
57,275
|
|
IVA receivable and
other assets
|
206,818
|
208,472
|
|
Total
assets
|
$
35,895,241
|
$
13,299,502
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||
|
Current
liabilities:
|
|
|
|
Checks
issued and payable
|
$
-
|
$
86,685
|
|
Accounts
payable
|
1,294,514
|
1,876,874
|
|
Accrued
liabilities
|
554,628
|
635,626
|
|
Payables to related
party
|
6,294
|
227,432
|
|
Notes payable to
bank
|
-
|
100,000
|
|
Export tax
assessment payable
|
-
|
1,120,730
|
|
Hillgrove advances
payable (Note 12)
|
1,134,221
|
378,074
|
|
Long-term debt,
current portion
|
40,770
|
52,122
|
|
Total current
liabilities
|
3,030,427
|
4,477,543
|
|
|
|
|
|
Long-term debt, net
of current portion
|
33,138
|
34,304
|
|
Hillgrove advances
payable (Note 12)
|
-
|
756,147
|
|
CARES Act note
payable
|
443,400
|
443,400
|
|
Stock payable to
directors for services
|
138,125
|
110,000
|
|
Asset retirement
obligations and accrued reclamation costs
|
293,451
|
291,719
|
|
Total
liabilities
|
3,938,541
|
6,113,113
|
|
Commitments and
contingencies (Note 6 and 11)
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred stock
$0.01 par value, 10,000,000 shares authorized:
|
|
|
|
Series A: -0-
shares issued and outstanding
|
-
|
-
|
|
Series B: 750,000
shares issued and outstanding
|
|
|
|
(liquidation
preference $945,000 and $937,500
|
|
|
|
respectively)
|
7,500
|
7,500
|
|
Series C: 177,904
shares issued and outstanding
|
|
|
|
(liquidation
preference $97,847 both years)
|
1,779
|
1,779
|
|
Series D: 1,751,005
shares issued and outstanding
|
|
|
|
(liquidation
preference $5,084,770 and $5,043,622
|
|
|
|
respectively)
|
17,509
|
17,509
|
|
Common stock, $0.01
par value, 150,000,000 shares authorized;
|
|
|
|
105,963,567 and
75,949,757 shares issued and outstanding, respectively
|
1,059,634
|
759,496
|
|
Additional paid-in
capital
|
63,856,560
|
39,050,899
|
|
Accumulated
deficit
|
(32,986,282
)
|
(32,650,794
)
|
|
Total stockholders'
equity
|
31,956,700
|
7,186,389
|
|
Total liabilities
and stockholders' equity
|
$
35,895,241
|
$
13,299,502
|
|
|
For the three
months ended
|
|
|
|
March
31,
2021
|
March
31,
2020
|
|
|
|
|
|
REVENUES
|
$
1,253,287
|
$
1,742,991
|
|
|
|
|
|
COST
OF REVENUES
|
1,041,130
|
1,641,814
|
|
|
|
|
|
GROSS
PROFIT
|
212,157
|
101,177
|
|
|
|
|
|
OPERATING
EXPENSES:
|
|
|
|
General
and administrative
|
170,050
|
199,971
|
|
Salaries
and benefits
|
76,659
|
94,969
|
|
Other
operating expenses
|
184,037
|
26,217
|
|
Professional
fees
|
123,137
|
84,958
|
|
TOTAL
OPERATING EXPENSES
|
553,883
|
406,115
|
|
|
|
|
|
INCOME (LOSS) FROM
OPERATIONS
|
(341,726
)
|
(304,938
)
|
|
|
|
|
|
OTHER INCOME
(EXPENSE):
|
|
|
|
Interest
income
|
8,493
|
804
|
|
Interest
expense
|
(2,255
)
|
(4,748
)
|
|
TOTAL
OTHER INCOME (EXPENSE)
|
6,238
|
(3,944
)
|
|
|
|
|
|
NET
LOSS
|
(335,488
)
|
(308,882
)
|
|
Preferred
dividends
|
(12,162
)
|
(12,162
)
|
|
|
|
|
|
Net loss available
to common stockholders
|
$
(347,650
)
|
$
(321,044
)
|
|
|
|
|
|
Net loss per share
of
|
|
|
|
common
stock:
|
|
|
|
Basic and
diluted
|
Nil
|
Nil
|
|
|
|
|
|
Weighted average
shares outstanding:
|
|
|
|
Basic
|
92,711,336
|
69,697,150
|
|
Diluted
|
92,711,336
|
69,697,150
|
|
|
Total Preferred
Stock
|
Common
Stock
|
Additional
|
|
Total
|
||
|
|
|
|
|
|
Paid
|
Accumulated
|
Stockholders'
|
|
Quarter ended
March 31, 2021
|
Shares
|
Amount
|
Shares
|
Amount
|
In
Capital
|
Deficit
|
Equity
|
|
|
|
|
|
|
|
|
|
|
Balances, December 31,
2020
|
2,678,909
|
$
26,788
|
75,949,757
|
$
759,496
|
$
39,050,899
|
$
(32,650,794
)
|
$
7,186,389
|
|
Issuance of common stock for
cash
|
-
|
-
|
26,290,000
|
262,900
|
24,734,100
|
-
|
24,997,000
|
|
Common stock issuance
costs
|
-
|
-
|
-
|
-
|
(1,654,820
)
|
-
|
(1,654,820
)
|
|
Common stock issued upon exercise
of warrants
|
-
|
-
|
3,723,810
|
37,238
|
1,726,381
|
-
|
1,763,619
|
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(335,488
)
|
(335,488
)
|
|
Balances, March 31,
2021
|
2,678,909
|
$
26,788
|
105,963,567
|
$
1,059,634
|
$
63,856,560
|
$
(32,986,282
)
|
$
31,956,700
|
|
|
Total Preferred
Stock
|
Common
Stock
|
Additional
|
|
Total
|
||
|
|
|
|
|
|
Paid
|
Accumulated
|
Stockholders'
|
|
Quarter ended
March 31, 2020
|
Shares
|
Amount
|
Shares
|
Amount
|
In
Capital
|
Deficit
|
Equity
|
|
|
|
|
|
|
|
|
|
|
Balances, December 31,
2019
|
2,678,909
|
$
26,788
|
69,661,436
|
$
696,614
|
$
37,107,730
|
$
(29,363,990
)
|
$
8,467,142
|
|
Common stock issued upon exercise
of warrants
|
-
|
-
|
250,000
|
2,500
|
60,000
|
-
|
62,500
|
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(308,882
)
|
(308,882
)
|
|
Balances, March 31,
2020
|
2,678,909
|
$
26,788
|
69,911,436
|
$
699,114
|
$
37,167,730
|
$
(29,672,872
)
|
$
8,220,760
|
|
United States Antimony Corporation and Subsidiaries
|
|||||
|
Consolidated Statements of Cash Flows - Unaudited
|
|
|
For the three
months ended
|
|
|
Cash Flows From
Operating Activities:
|
March
31,
2021
|
March
31,
2020
|
|
Net income
(loss)
|
$
(335,488
)
|
$
(308,882
)
|
|
Adjustments to
reconcile net income (loss) to net cash
|
|
|
|
provided
(used) by operating activities:
|
|
|
|
Depreciation and
amortization
|
222,464
|
226,281
|
|
Accretion of asset
retirement obligation
|
1,732
|
2,654
|
|
Common stock
payable for directors fees
|
28,125
|
28,125
|
|
Write-down of
inventory to net realizable value
|
57,530
|
22,475
|
|
Other non-cash
items
|
(661
)
|
(660
)
|
|
Change
in:
|
|
|
|
Accounts
receivable
|
(298,933
)
|
54,761
|
|
Inventories
|
(125,067
)
|
(39,124
)
|
|
IVA receivable and
other assets
|
(50,546
)
|
2,083
|
|
Accounts
payable
|
(582,360
)
|
(24,528
)
|
|
Accrued
liabilities
|
(80,998
)
|
(38,147
)
|
|
Export tax
assessment payable
|
(1,120,730
)
|
23,774
|
|
Payables to related
parties
|
(164,922
)
|
14,923
|
|
Net cash (used) by
operating activities
|
(2,449,854
)
|
(36,265
)
|
|
|
|
|
|
Cash Flows From
Investing Activities:
|
|
|
|
Purchase of
properties, plants and equipment
|
(23,298
)
|
(96,271
)
|
|
Net cash (used) by
investing activities
|
(23,298
)
|
(96,271
)
|
|
|
|
|
|
Cash Flows From
Financing Activities:
|
|
|
|
Change in checks
issued and payable
|
(86,685
)
|
56,102
|
|
Net borrowing from
factor
|
-
|
6,347
|
|
Payments on
advances from related party
|
(56,216
)
|
(13,933
)
|
|
Proceeds from
issuance of common stock, net of issuance costs
|
23,342,180
|
-
|
|
Proceeds from
exercise of warrants
|
1,763,619
|
-
|
|
Borrowing on notes
payable to bank
|
-
|
2,488
|
|
Principal paid on
notes payable to bank
|
(100,000
)
|
-
|
|
Principal payments
of long-term debt
|
(12,518
)
|
(10,906
)
|
|
Net cash provided
by financing activities
|
24,850,380
|
40,098
|
|
NET INCREASE
(DECREASE) IN CASH
|
|
|
|
AND
CASH EQUIVALENTS AND RESTRICTED CASH
|
22,377,228
|
(92,438
)
|
|
Cash and cash
equivalents and restricted cash at beginning of period
|
722,377
|
172,767
|
|
Cash and cash
equivalents and restricted cash at end of period
|
$
23,099,605
|
$
80,329
|
|
|
57,275
|
|
|
NONCASH INVESTING
AND FINANCING ACTIVITIES:
|
|
|
|
Common stock issued
for warrants
|
$
-
|
$
62,500
|
|
|
March
31,
2021
|
March
31,
2020
|
|
Warrants
|
2,471,089
|
452,041
|
|
Convertible
preferred stock
|
1,751,005
|
1,751,005
|
|
Total possible
dilution
|
4,222,094
|
2,203,046
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2021
|
2020
|
|
Antimony
|
$
657,107
|
$
1,121,425
|
|
Zeolite
|
519,947
|
559,360
|
|
Precious
metals
|
76,233
|
62,206
|
|
|
$
1,253,287
|
$
1,742,991
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2021
|
2020
|
|
United
States
|
$
1,165,513
|
$
1,566,237
|
|
Canada
|
87,774
|
176,754
|
|
|
$
1,253,287
|
$
1,742,991
|
|
Sales
to Three
|
For the
Period Ended
|
|
|
Largest
Customers
|
March
31,
2021
|
March 31,
2020
|
|
Zeo
Inc.
|
$
152,317
|
$
-
|
|
GE Chaplin,
Inc.
|
298,150
|
114,291
|
|
Nyacol
Technologies
|
-
|
106,161
|
|
Mexichem Specialty
Compounds
|
327,670
|
413,993
|
|
|
$
778,137
|
$
634,445
|
|
%
of Total Revenues
|
62.09
%
|
36.40
%
|
|
Largest
|
|
|
|
Accounts
Receivable
|
March
31,
2021
|
December
31,
2020
|
|
Mexichem Specialty
Compounds
|
$
185,804
|
$
-
|
|
GE Chaplin,
Inc.
|
102,408
|
-
|
|
Earth Innovations
Inc.
|
-
|
68,055
|
|
|
$
288,212
|
$
68,055
|
|
%
of Total Receivables
|
53.61
%
|
28.52
%
|
|
|
March
31,
2021
|
December
31,
2020
|
|
Antimony
Metal
|
$
25,238
|
$
268,100
|
|
Antimony
Oxide
|
360,566
|
67,377
|
|
Antimony
Ore
|
167,945
|
95,880
|
|
Total
antimony
|
553,749
|
431,357
|
|
Zeolite
|
164,001
|
218,856
|
|
|
$
717,750
|
$
650,213
|
|
At March 31, 2021 and
December 31, 2020, the Company had the following notes payable to
bank:
|
||
|
|
|
|
|
|
2021
|
2020
|
|
Promissory note
payable to First Security Bank of Missoula,
|
|
|
|
bearing interest at
3.150%, payable on demand, collateralized
|
|
|
|
by a lien on
Certificate of Deposit
|
$
-
|
$
99,999
|
|
|
|
|
|
Promissory note
payable to First Security Bank of Missoula,
|
|
|
|
bearing interest at
3.150%, payable on demand, collateralized
|
|
|
|
by a lien on
Certificate of Deposit
|
-
|
1
|
|
|
|
|
|
Total notes payable
to the bank
|
$
-
|
$
100,000
|
|
Long-Term debt at
March 31, 2021 and December 31, 2020 is as follows:
|
March
31,
|
December
31,
|
|
|
2021
|
2020
|
|
Note payable to Zeo
Inc., non interest bearing,
|
|
|
|
payable in 11
quarterly installments of $8,300 with a final payment of
$8,700;
|
|
|
|
maturing December
2022; uncollateralized.
|
$
58,500
|
$
66,800
|
|
Note payable to Cat
Financial Services, bearing interest at 6%;
|
|
|
|
payable in monthly
installments of $778; maturing
|
|
|
|
December 2022;
collateralized by equipment.
|
15,408
|
17,480
|
|
Note payable to
Phyllis Rice, bearing interest
|
|
|
|
at 1%; payable in
monthly installments of $2,000; originally maturing
|
|
|
|
March 2015;
collateralized by equipment.
|
-
|
2,146
|
|
|
73,908
|
86,426
|
|
Less current
portion
|
(40,770
)
|
(52,122
)
|
|
Long-term
portion
|
$
33,138
|
$
34,304
|
|
12 Months Ending
March 31,
|
Principal
Payment
|
|
2022
|
40,770
|
|
2023
|
33,138
|
|
|
$
73,908
|
|
|
Number of
Warrants
|
Exercise
Prices
|
|
Balance December
31, 2019
|
702,041
|
$
0.25 - $0.65
|
|
Issued
|
5,742,858
|
$
0.46
|
|
Exercised
|
(250,000
)
|
$
0.25
|
|
Balance December
31, 2020
|
6,194,899
|
$
0.46 - $0.65
|
|
Issued
|
-
|
|
|
Exercised
|
(3,723,810
)
|
$
0.46 - $0.65
|
|
Balance March 31,
2021
|
2,471,089
|
$
0.46 - $0.65
|
|
Shares
|
Exercise
Price
|
Expiration
Date
|
|
185,374
|
$
0.65
|
2022
|
|
2,285,715
|
$
0.46
|
2025
|
|
2,471,089
|
|
|
|
Properties,
plants
|
March
31,
|
December
31,
|
|
and
equipment, net:
|
2021
|
2020
|
|
Antimony
|
|
|
|
United
States
|
$
1,629,846
|
$
1,637,738
|
|
Mexico
|
7,495,331
|
7,635,410
|
|
Subtotal
Antimony
|
9,125,177
|
9,273,148
|
|
Precious
metals
|
924,707
|
933,885
|
|
Zeolite
|
976,544
|
1,018,561
|
|
Total
|
$
11,026,428
|
$
11,225,594
|
|
|
For the three
months ended
|
|
|
Capital
expenditures:
|
March
31,
2021
|
March
31,
2020
|
|
Antimony
|
|
|
|
United
States
|
$
-
|
$
23,121
|
|
Mexico
|
4,872
|
26,765
|
|
Subtotal
Antimony
|
4,872
|
49,886
|
|
Precious
Metals
|
18,426
|
38,521
|
|
Zeolite
|
-
|
7,864
|
|
Total
|
$
23,298
|
$
96,271
|
|
Segment
Operations for the three
|
Antimony
|
Antimony
|
Total
|
Precious
|
Bear
River
|
|
|
months ended
March 31, 2021
|
USAC
|
Mexico
|
Antimony
|
Metals
|
Zeolite
|
Totals
|
|
|
|
|
|
|
|
|
|
Total revenues
|
$
657,107
|
$
-
|
$
657,107
|
$
76,233
|
$
519,947
|
$
1,253,287
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
7,891
|
144,952
|
152,843
|
27,604
|
42,017
|
222,464
|
|
|
|
|
|
|
|
|
|
Income (loss) from
operations
|
(218,669
)
|
(238,568
)
|
(457,237
)
|
48,630
|
66,881
|
(341,726
)
|
|
|
|
|
|
|
|
|
|
Other income
(expense):
|
6,635
|
-
|
6,635
|
-
|
(397
)
|
6,238
|
|
|
|
|
|
|
|
|
|
NET INCOME
(LOSS)
|
$
(212,034
)
|
$
(238,568
)
|
$
(450,602
)
|
$
48,630
|
$
66,484
|
$
(335,488
)
|
|
Segment
Operations for the three
|
Antimony
|
Antimony
|
Total
|
Precious
|
Bear
River
|
|
|
months ended
March 31, 2020
|
USAC
|
Mexico
|
Antimony
|
Metals
|
Zeolite
|
Totals
|
|
|
|
|
|
|
|
|
|
Total revenues
|
$
1,121,425
|
$
-
|
$
1,121,425
|
$
62,206
|
$
559,360
|
$
1,742,991
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
7,395
|
146,098
|
153,493
|
23,598
|
49,190
|
226,281
|
|
|
|
|
|
|
|
|
|
Income (loss) from
operations
|
239,352
|
(719,066
)
|
(479,714
)
|
38,608
|
136,168
|
(304,938
)
|
|
|
|
|
|
|
|
|
|
Other income
(expense):
|
(2,915
)
|
-
|
(2,915
)
|
-
|
(1,029
)
|
(3,944
)
|
|
|
|
|
|
|
|
|
|
NET INCOME
(LOSS)
|
$
236,437
|
$
(719,066
)
|
$
(482,629
)
|
$
38,608
|
$
135,139
|
$
(308,882
)
|
|
|
Three
Months
|
Three
Months
|
|
|
Ended
|
Ended
|
|
Antimony
- Combined USA and Mexico
|
March
31,
2021
|
March
31,
2020
|
|
Lbs of Antimony
Metal USA
|
181,969
|
166,908
|
|
Lbs of Antimony
Metal Mexico:
|
-
|
128,545
|
|
Total
Lbs of Antimony Metal Sold
|
181,969
|
295,453
|
|
Average Sales
Price/Lb Metal
|
$
3.61
|
$
3.06
|
|
Net
loss/Lb Metal
|
$
(2.48
)
|
$
(1.63
)
|
|
|
|
|
|
Gross antimony
revenue - net of discount
|
657,107
|
902,746
|
|
Tri-sulfide
revenue
|
-
|
218,679
|
|
Total
revenue
|
$
657,107
|
$
1,121,425
|
|
|
|
|
|
Cost of sales -
domestic
|
(543,322
)
|
(533,289
)
|
|
Cost of sales -
Mexico
|
(26,318
)
|
(684,061
)
|
|
Operating
expenses
|
(544,704
)
|
(383,789
)
|
|
Non-operating
expenses
|
6,635
|
(2,915
)
|
|
|
(1,107,709
)
|
(1,604,054
)
|
|
|
|
|
|
Net
loss - antimony
|
(450,602
)
|
(482,629
)
|
|
Depreciation,&
amortization
|
152,843
|
153,493
|
|
EBITDA
- antimony
|
$
(297,759
)
|
$
(329,136
)
|
|
|
|
|
|
Precious
Metals
|
|
|
|
Ounces
sold
|
|
|
|
Gold
|
7.28
|
15.00
|
|
Silver
|
3,354
|
5,048
|
|
|
|
|
|
Gross precious
metals revenue
|
$
76,233
|
$
62,206
|
|
Production costs,
royalties, and shipping costs
|
(27,604
)
|
(23,598
)
|
|
Net
income - precious metals
|
48,629
|
38,608
|
|
Depreciation
|
27,604
|
23,598
|
|
EBITDA
- precious metals
|
$
76,233
|
$
62,206
|
|
|
|
|
|
Zeolite
|
|
|
|
Tons
sold
|
2,743
|
2,809
|
|
Average Sales
Price/Ton
|
$
189.55
|
$
199.13
|
|
Net
income (Loss)/Ton
|
$
24.24
|
$
48.11
|
|
|
|
|
|
Gross zeolite
revenue
|
$
519,947
|
$
559,360
|
|
Cost of
sales
|
(443,886
)
|
(400,866
)
|
|
Operating
expenses
|
(9,179
)
|
(22,326
)
|
|
Non-operating
expenses
|
(397
)
|
(1,029
)
|
|
Net
income - zeolite
|
66,485
|
135,139
|
|
Depreciation
|
42,017
|
49,190
|
|
EBITDA
- zeolite
|
$
108,502
|
$
184,329
|
|
|
|
|
|
Company-wide
|
|
|
|
Gross
revenue
|
$
1,253,287
|
$
1,742,991
|
|
Production
costs
|
(1,041,130
)
|
(1,641,814
)
|
|
Operating
expenses
|
(553,883
)
|
(406,115
)
|
|
Non-operating
expenses
|
6,238
|
(3,944
)
|
|
Net
income (loss)
|
(335,488
)
|
(308,882
)
|
|
Depreciation,&
amortization
|
222,464
|
226,281
|
|
EBITDA
|
$
(113,024
)
|
$
(82,601
)
|
|
Precious
Metal Sales Silver/Gold
|
For
the three months ended March 31,
|
|
|
Montana
|
2021
|
2020
|
|
Ounces Gold Shipped
(Au)
|
7.28
|
15.00
|
|
Ounces Silver
Shipped (Ag)
|
3,354.00
|
5,048.00
|
|
Total
Revenues
|
$
76,233
|
$
62,206
|
|
Financial
Condition and Liquidity
|
March
31,
2021
|
December
31,
2020
|
|
|
|
|
|
Current
assets
|
$
24,604,720
|
$
1,808,161
|
|
Current
liabilities
|
(3,030,427
)
|
(4,477,543
)
|
|
Net
Working Capital
|
$
21,574,293
|
$
(2,669,382
)
|
|
|
For the
Three Months Ended
|
|
|
|
March 31,
2021
|
March 31,
2020
|
|
Cash provided
(used) by operations
|
$
(2,449,854
)
|
$
(36,265
)
|
|
Cash provided by
collection of note receivable
|
|
|
|
Cash provided
(used) by investing:
|
|
|
|
Cash used for
capital outlay
|
(23,298
)
|
(96,271
)
|
|
Cash provided
(used) by financing:
|
|
|
|
Payments on notes
payable to bank
|
(100,000
)
|
-
|
|
Proceeds from notes
payable to bank
|
-
|
2,488
|
|
Proceeds from
common stock issued, net
|
23,342,180
|
62,500
|
|
Proceeds from
exercise of warrants
|
1,763,619
|
-
|
|
Principal paid on
long-term debt
|
(12,518
)
|
(10,906
)
|
|
Payments on
advances from related party
|
(56,216
)
|
-
|
|
Checks issued and
payable
|
(86,685
)
|
56,102
|
|
Net
change in cash and restricted cash
|
$
22,377,228
|
$
(22,352
)
|
|
By: /s/
John C. Gustaven
|
|
|
Date:
May 15, 2021
|
|
|
John C.
Gustaven, Interim CEO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
/s/
Russell C.
Lawrence
|
|
|
Date:
May 15, 2021
|
|
|
Russell
C. Lawrence, Interim President & Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|